High Low - Sun Pharmaceutical Industries Ltd.
Search Company
Registered Address
Registered Office : Sun Pharma Advanced Research Centre (SPARC), Tandalja,
Vadodra, Gujarat - 390012
Tel: 0265-6615500, 6615600, 6615700
Fax: 0265-2354897
Email : secretarial@sunpharma.com
Website : http://www.sunpharma.com
Key Officials
Name Designation
Mr. Anoop Deshpande Co. Secretary & Compl. Officer
Mr. Abhay Gandhi CEO - North America
Mr. Kirti Ganorkar Head - Business Process
Listings
BSE , BSE , MCXSX , NSE , NSE ,  
Standalone Consolidated
You are viewing standalone data.
Quarterly Results
Dec 25 Sep 25 Jun 25
Sales 5,687.77 4,548.11 5,601.96
Other Income 179.90 72.79 103.69
Total Expenses 3,515.90 3,026.43 3,382.56
Operating Profit 2,171.87 1,521.68 2,219.40
Interest 244.17 248.33 223.29
Gross Profit 1,694.33 1,008.05 1,771.55
Provisions Made 0.00 0.00 0.00
Depreciation 338.53 336.30 299.03
Taxation 482.06 107.53 431.35
Net Profit / Loss 705.44 564.22 753.53
Equity Capital 239.93 239.93 239.93
Balance Sheet
Mar 25 Mar 24 Mar 23
Share Capital 239.93 239.93 239.93
Reserve & Surplus 24,099.92 23,454.47 23,508.43
Revaluation Reserve 0.00 0.00 0.00
Networth 24,339.85 23,694.40 23,748.36
Total debt 10,954.47 11,046.61 7,592.67
Total Liability 35,294.32 34,741.01 31,341.03
Net Block 6,988.52 7,736.74 8,711.67
Capital work in progress 939.23 766.11 852.91
Investment 12,410.11 12,429.97 12,616.40
Net current asset 14,956.46 13,808.19 9,160.05
Miscellaneous expenses 0.00 0.00 0.00
Total Assets 35,294.32 34,741.01 31,341.03
Income Statement
  Mar25 Mar24 Mar23
Sales 23,003.33 20,275.17 20,812.14
Other Income 369.43 465.76 279.03
Total Expenses 16,210.71 14,687.56 14,339.28
Operating Profit 6,792.62 5,587.61 6,472.86
Interest 893.21 784.08 472.18
Adjusted PBDIT 7,162.05 6,053.37 6,751.89
Depreciation 1,238.27 1,600.62 1,600.87
Adjusted PBT 5,030.57 3,668.67 4,678.84
Taxation 747.95 591.47 50.33
Net Profit / Loss 4,282.62 2,858.18 1,690.72
Key Ratios
  Mar25 Mar24 Mar23
OPM (%) 29.52 27.55 31.10
GPM (%) 24.14 19.66 23.40
NPM (%) 18.61 14.09 8.12
Earning Retention Ratio 15.62 5.82 45.57
Return on networth (%) 17.59 12.06 7.11
EPS (Rs.) 17.85 11.91 7.05
Dividend payout Ratio 84.38 101.39 149.00
Longterm Debt-Equity Ratio 0.00 0.46 0.31
Current Ratio 2.87 3.18 1.95
Fixed Asset Turnover Ratio 0.65 0.61 0.68
Inventory 0.65 0.58 0.66
Interest coverage Ratio 8.02 7.72 14.30
Registrar Details
MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel : 022-49186270
Fax : 49186060
Market Performance
Exchange BSE NSE
Last Traded Price (Rs.) 1,694.00 1,695.10
Last Traded Date 06/02/2026 06/02/2026
Last Traded Time 04:01:00 PM 03:57:46 PM
Change (%) -0.49% -0.44%
Day's Open (Rs.) 1,708.05 1,709.00
Previous Close (Rs.) 1,702.30 1,702.60
Day's High (Rs.) 1,708.10 1,709.00
Day's Low (Rs.) 1,690.00 1,689.60
Volume (Rs. In Lacs) 261.89 21647.88
Bid Price (Rs.) 0.00 1,695.10
Bid Quantity 71
Offer Price (Rs.) 0.00 0.00
Offer Quantity
Exchange Code 524715 SUNPHARMAEQ
Exchange Group A Nifty
Board Meetings
Date Purpose
31/01/2026 Quarterly Results & Interim Dividend
05/11/2025 Quarterly Results
31/07/2025 Quarterly Results
Corporate News
Sun Pharmaceutical has declared 1100% Interim dividend for the financial year March 2026
Sun Pharmaceutical - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Sun Pharmaceutical - Analysts/Institutional Investor Meet/Con. Call Updates
Sun Pharmaceutical - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Sun Pharmaceutical - Analysts/Institutional Investor Meet/Con. Call Updates
Share Holding Pattern as on 31/12/2025
Major Holder No. of Shares Percentage (%)
Promoters 1,307,119,535 54.48
Institutional Investors 886,319,361 36.94
Other Investors 76,334,519 3.18
General Public 129,561,555 5.40